NF-κB
transcription factors have a critical role in regulating cell survival and apoptosis. We have previously shown that 4-(3-Cl-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic
acid (3-Cl-AHPC), an adamantyl-substituted
retinoid molecule, induced apoptosis and required NF-κB activation in prostate and
breast carcinoma cells. Here, we show that
3-Cl-AHPC activated both IκB
kinase (IKK)α and IKKβ with subsequent activation of the canonical and noncanonical NF-κB pathways in the human
breast carcinoma and
leukemia cell lines. 3-Cl-AHPC-mediated activation of the NF-κB canonical pathway occurred within 6 h, whereas maximal activation of the NF-κB noncanonical pathway required 48 h. Knockout of IKKα or IKKβ expression in mouse embryonic fibroblast cells and knockdown of IKKα or IKKβ in MDA-MB-468 cells resulted in the inhibition of 3-Cl-AHPC-mediated apoptosis, indicating that activation of canonical and noncanonical pathways are required for maximal 3-Cl-AHPC-mediated apoptosis.
3-Cl-AHPC activation of the noncanonical pathway was preceded by
caspase-mediated decrease in the E3-ligase c-IAP1 with subsequent stabilization of NF-κB-inducing
kinase (NIK) expression, increased binding of NIK by
TRAF3, activation of IKKα, and the resultant increased levels of RelB and p52. Increased expression of c-IAP1 blocked 3-Cl-AHPC-mediated stabilization of NIK levels and 3-Cl-AHPC-mediated apoptosis. Cdc37 expression was required for activation of IKKα and IKKβ by
3-Cl-AHPC. These findings suggest that NF-κB pathways have an important role in 3-Cl-AHPC-mediated apoptosis.